On this page:
We host of number of hepatitis B studies via our dedicated clinical research facility. Dr Daniel Forton is principal investigator for a number of studies looking at novel hepatitis B therapies.
Non-alcoholic fatty liver disease
We have participated in a number of commercial-partnered clinical research studies looking at new screening methods, diagnostic modalities and treatments for non-alcoholic fatty liver disease.
Alcohol-related Liver Disease Treatments
We have also participated in multiple studies evaluating the treatments if life-threatening alcohol-related liver inflammatory conditions.
Dr Hughes acts as principal investigator to national studies investigating treatments for bleeding within the digestive tract related portal hypertension related to liver cirrhosis.